TrialsgrambetaRCTs are beautiful

SGEM#235: Edoxaban for Cancer Associated VTE – Would the NEJM Lie to You?

1 ensayo

Ensayos extraídos del pódcast de Dr. Ken Milne

  • 2018Hokusai VTE CancerAnticoagulation & AntithromboticsIn 1046 patients with cancer-associated venous thromboembolism, edoxaban was noninferior to dalteparin for recurrent VTE or major bleeding at 12 months.